News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReCor Medical Receives CE Mark for its Generation 2, Ultrasound-based PARADISE™ Renal Denervation System


1/24/2013 9:43:49 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCor Medical announced today that it has received CE mark for its next-generation PARADISE system, a minimally invasive 6Fr over-the-wire (OTW) ultrasound device for treating resistant high blood pressure. Additionally, the treatment parameters of Gen 2 have been further enhanced to reduce energy delivery to 30 seconds by maximizing cooling of the endothelium and efficiently treating the nerves circumferentially. A live case is planned Friday, January 25, 2013, at the ‘LINC’ (Leipzig Interventional Course) meeting in Leipzig, Germany.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES